ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CTEC Convatec Group Plc

262.80
1.00 (0.38%)
Last Updated: 15:53:27
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Convatec Group Plc LSE:CTEC London Ordinary Share GB00BD3VFW73 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.00 0.38% 262.80 262.60 263.00 264.00 261.20 262.20 546,831 15:53:27
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Med, Dental, Hosp Eq-whsl 2.14B 130.3M 0.0636 41.35 5.39B

ConvaTec Group PLC Director/PDMR Shareholding (3300Y)

04/12/2017 3:15pm

UK Regulatory


Convatec (LSE:CTEC)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Convatec Charts.

TIDMCTEC

RNS Number : 3300Y

ConvaTec Group PLC

04 December 2017

4 December 2017

ConvaTec Group Plc

("ConvaTec" or "the Company")

Director/PDMR Shareholding

The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

On 4 December 2017, Dr Ros Rivaz, a Non-Executive Director and a PDMR, purchased 4,908 Shares at GBP2.02 per share. Dr Rivaz' resulting shareholding is 4,908 Shares.

The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 
  1      Details of the person discharging managerial responsibilities/person 
          closely associated 
----  ---------------------------------------------------------------------------------------------------------------- 
  a)    Name                                              Dr Rosalind Rivaz 
----  ------------------------------------------------  -------------------------------------------------------------- 
  2     Reason for the notification 
----  ---------------------------------------------------------------------------------------------------------------- 
  a)    Position/Status                                   Non-Executive Director 
----  ------------------------------------------------  -------------------------------------------------------------- 
  b)    Initial notification/Amendment                    Initial notification 
----  ------------------------------------------------  -------------------------------------------------------------- 
  3     Details of the issuer, emission allowance market participant, 
         auction platform, auctioneer or auction monitor 
----  ---------------------------------------------------------------------------------------------------------------- 
  a)    Name                                              ConvaTec Group Plc 
----  ------------------------------------------------  -------------------------------------------------------------- 
  b)    LEI                                               213800LS272L4FIDOH92 
----  ------------------------------------------------  -------------------------------------------------------------- 
  4     Details of the transaction(s): section to be repeated for 
         (i) each type of instrument; (ii) each type of transaction; 
         (iii) each date; and (iv) each place where transactions have 
         been conducted 
----  ---------------------------------------------------------------------------------------------------------------- 
  a)    Description of the financial                       Ordinary shares of 10p each in ConvaTec Group Plc 
         instrument, type of instrument                    ("Shares") 
         Identification code                               GB00BD3VFW73 
----  ------------------------------------------------  -------------------------------------------------------------- 
  b)    Nature of the transaction                               Purchase of Shares 
----  ------------------------------------------------  -------------------------------------------------------------- 
  c)    Price(s) and volume(s)                            Price(s)                                         Volume(s) 
                                                           GBP2.024914                                      4,908 
----  ------------------------------------------------  -----------------------------------------------  ------------- 
  d)    Aggregated information 
         - Aggregated volume                                4,908 
         - Price                                            GBP9,938.28 
----  ------------------------------------------------  -------------------------------------------------------------- 
  e)    Date of the transaction                           4 December 2017 
----  ------------------------------------------------  -------------------------------------------------------------- 
  f)    Place of the transaction                          London Stock Exchange, Main Market (XLON) 
----  ------------------------------------------------  -------------------------------------------------------------- 
 

Enquiries

Media

   Bobby Leach, VP Group Corporate Affairs, ConvaTec                        +44 (0)7770 842 226 

Alastair Elwen, Finsbury +44 (0)207 251 3801

Analysts and Investors

John Crosse, VP Investor Relations, ConvaTec +44 (0)7500 141 435

   Kirsty Law, Director Investor Relations, ConvaTec                               +44 (0)7470 909 582 

investorrelations@convatec.com

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLLFLEFSLSIID

(END) Dow Jones Newswires

December 04, 2017 10:15 ET (15:15 GMT)

1 Year Convatec Chart

1 Year Convatec Chart

1 Month Convatec Chart

1 Month Convatec Chart

Your Recent History

Delayed Upgrade Clock